Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26904556 |
CN |
81 | 1 |
Sluggishness, Amnesia, Asthenia, Gait disturbance, |
||||
CARBAMAZEPINE, |
||||
| 202 | 26904619 |
EU |
55 | |
Choroidal effusion, Urinary retention, Sciatica, Discomfort, Depressed mood, Sensitivity to weather change, Decreased appetite, Post procedural complication, Diarrhoea, Speech disorder, Sticky skin, Blood pressure decreased, Limb discomfort, Nervousness, White blood cell count decreased, Haemoglobin decreased, Parosmia, Asthenia, Muscle spasms, Weight decreased, Decreased immune responsiveness, Pain, Gastrointestinal pain, Gastric pH decreased, Increased appetite, Chills, Gallbladder disorder, Cystitis, Tremor, Pain in extremity, Dysuria, Dizziness postural, Urine abnormality, Arthralgia, Weight increased, Malaise, Injection site pain, Dysuria, Dehydration, Alopecia, Gait disturbance, Mental disorder, Nipple disorder, Muscle spasms, Feeling abnormal, Insomnia, Dry skin, Abdominal distension, Dyspepsia, Fatigue, Nausea, Vomiting, Constipation, Abdominal pain upper, Toxicity to various agents, Vomiting, Nausea, Abdominal pain, Abdominal discomfort, Cystitis, Palpitations, Daydreaming, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, MORPHINE, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, DIMENHYDRINATE, DIMENHYDRINATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FULVESTRANT, PHYTONADIONE, CALCIUM, ERGOCALCIFEROL, FULVESTRANT, MENADIONE, |
||||
| 203 | 26904638 |
CA |
82 | 2 |
Cardiac failure, Mental impairment, Illness, Dizziness, Loss of personal independence in daily activities, Fatigue, Dyspnoea, Gait disturbance, Confusional state, |
||||
| 204 | 26904923 |
US |
2 | |
Diplegia, Product administration error, Incorrect dose administered, Muscle tightness, Gait disturbance, Tremor, |
||||
OFATUMUMAB, BACLOFEN, DIAZEPAM, DULOXETINE HYDROCHLORIDE, |
||||
| 205 | 26905328 |
CA |
72 | 2 |
Arthralgia, Back pain, Blood creatinine increased, Bursitis, Deafness, Disease progression, Disease recurrence, Drug intolerance, Dry mouth, Electric shock sensation, Feeling abnormal, Gait disturbance, Glomerular filtration rate decreased, Headache, Hypersensitivity, Hypoaesthesia, Inflammation, Inflammatory marker increased, Joint swelling, Limb discomfort, Movement disorder, Musculoskeletal discomfort, Musculoskeletal stiffness, Neck pain, Nerve compression, Pain, Pain in extremity, Pain in jaw, Paraesthesia, Polyarthritis, Tinnitus, Tachycardia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TOFACITINIB, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, TRIAMTERENE CAPSULES, TRIAMTERENE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 206 | 26905387 |
US |
71 | 1 |
Sepsis, Gait disturbance, Pain, Abdominal pain, Tendon pain, Ligament pain, Myalgia, Decubitus ulcer, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 207 | 26905784 |
CO |
77 | 2 |
Blindness, Deafness, Chest injury, Fall, Viral infection, Back injury, Facial pain, Joint swelling, Influenza, Pain, Arthralgia, Plantar fasciitis, Gastrooesophageal reflux disease, Illness, Abdominal discomfort, Dizziness, Erythema, Burning sensation, Rash, Ocular icterus, Lacrimation increased, Photophobia, Headache, Gingival pain, Amnesia, Alopecia, Odynophagia, Facial asymmetry, Rhinorrhoea, Gait disturbance, Depression, Skin exfoliation, Coordination abnormal, |
||||
DENOSUMAB, |
||||
| 208 | 26905808 |
US |
67 | |
Fatigue, Balance disorder, Gait disturbance, Dehydration, Hepatic pain, Pain, Asthenia, Weight decreased, White blood cell count decreased, Red blood cell count increased, Flatulence, Nausea, Diarrhoea, Pruritus, Abdominal pain upper, Vomiting, Dizziness, |
||||
RESMETIROM, RESMETIROM, QUININE, MELOXICAM, MELOXICAM, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, LACTULOSE, ATOGEPANT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MAGNESIUM, CALCIUM, IRON, BUPROPION HYDROCHLORIDE, EZETIMIBE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, SUMATRIPTAN, FISH OIL, ERGOCALCIFEROL, CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, |
||||
| 209 | 26905814 |
US |
78 | |
Weight increased, Gait disturbance, Hypersensitivity, |
||||
RESMETIROM, RESMETIROM, AMLODIPINE BESYLATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VITAMIN E, VITAMIN E, OMEPRAZOLE MAGNESIUM, MELATONIN, LOSARTAN POTASSIUM, LOSARTAN, ISOSORBIDE DINITRATE, IRON, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CELECOXIB, BACLOFEN, |
||||
| 210 | 26905833 |
US |
67 | 2 |
Knee arthroplasty, Gait disturbance, Loss of personal independence in daily activities, |
||||
RISANKIZUMAB-RZAA, |
||||
| 211 | 26905953 |
US |
1 | |
Lower limb fracture, Syncope, Fall, Blood pressure decreased, Balance disorder, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 212 | 26906162 |
US |
1 | |
Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 213 | 26906322 |
US |
67 | 2 |
Productive cough, Gait disturbance, Dyspnoea, Fatigue, |
||||
DUPILUMAB, |
||||
| 214 | 26906396 |
US |
78 | 2 |
Shoulder fracture, Dementia, Peripheral swelling, Nausea, Gait disturbance, Intentional dose omission, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 215 | 26906422 |
US |
1 | |
Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, DICYCLOMINE HYDROCHLORIDE, GABAPENTIN, MELOXICAM, |
||||
| 216 | 26906451 |
US |
2 | |
Chest pain, Back pain, Blood pressure increased, Gait disturbance, Hypoaesthesia, Drooling, Muscle spasms, Arthralgia, Hyperhidrosis, Anxiety, Walking aid user, |
||||
RAVULIZUMAB, |
||||
| 217 | 26906500 |
CO |
77 | 2 |
Memory impairment, COVID-19, Headache, Anxiety, Blister, Gastroenteritis viral, Psychiatric symptom, Pruritus, Urticaria, Illness, Bone disorder, Malaise, Cough, Gastrooesophageal reflux disease, Fall, Gait disturbance, Erythema, Dry skin, Angioedema, Swelling face, Peripheral swelling, Dyspnoea, Fatigue, Back pain, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FEXOFENADINE, |
||||
| 218 | 26906536 |
US |
79 | 2 |
Loss of consciousness, Gait disturbance, Drug ineffective, Product use issue, Product use in unapproved indication, Dizziness, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NASAL, SODIUM CHLORIDE, SALINE, SALINE NASAL SPRAY, (SALINE), ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, CETIRIZINE HYDROCHLORIDE, DEXLANSOPRAZOLE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ERGOCALCIFEROL, ESCITALOPRAM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MAGNESIUM, TAMSULOSIN HYDROCHLORIDE, BENZONATATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MIRTAZAPINE, AMLODIPINE BESYLATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FUROSEMIDE, |
||||
| 219 | 26906580 |
AU |
2 | |
Gait disturbance, Flushing, Headache, Vomiting, Dizziness, Decreased appetite, Pain, Influenza, Nausea, Pyrexia, Pain, Headache, |
||||
| 220 | 26906964 |
US |
79 | 2 |
Gait disturbance, Arthritis, Illness, |
||||
SECUKINUMAB, RIBOCICLIB, |
||||
| 221 | 26907052 |
US |
74 | 2 |
Concussion, Gait disturbance, Knee arthroplasty, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 222 | 26907420 |
EU |
47 | 1 |
Impaired gastric emptying, Ileus paralytic, Spinal fracture, Multiple acyl-coenzyme A dehydrogenase deficiency, Gait disturbance, Seizure, Muscle spasms, Myalgia, Muscular weakness, Muscle twitching, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE, |
||||
| 223 | 26907518 |
CA |
43 | 2 |
Breast cancer stage II, Retinitis, Incorrect route of product administration, Off label use, Medication error, Fibromyalgia, Arthropathy, Folliculitis, Gait disturbance, Abdominal discomfort, Autoimmune disorder, Fatigue, Visual impairment, Hypocholesterolaemia, Product use issue, |
||||
DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, PREGABALIN, CELECOXIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OXYCODONE, OXYCODONE, OXYCODONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, |
||||
| 224 | 26907532 |
GB |
2 | |
Cerebrovascular accident, Dizziness, Gait disturbance, Visual impairment, Eye movement disorder, Vision blurred, Cerebral disorder, Speech disorder, Chest pain, |
||||
SIPONIMOD, SIPONIMOD, |
||||
| 225 | 26908052 |
US |
61 | 2 |
Chills, Feeling hot, Feeling cold, Discomfort, Gait disturbance, Head discomfort, Headache, Abdominal discomfort, Fatigue, Nausea, |
||||
ORFORGLIPRON, |
||||
| 226 | 26908856 |
US |
59 | |
Hypoaesthesia, Arthralgia, Bone pain, Vision blurred, Abdominal distension, Swelling face, Peripheral swelling, Gait disturbance, Dyspnoea, |
||||
| 227 | 26909447 |
US |
59 | 2 |
Arthritis, Dizziness, Back disorder, Bursitis, Gait disturbance, Pain, Somnolence, |
||||
LUMATEPERONE, PREGABALIN, |
||||
| 228 | 26912187 |
1 | ||
Night sweats, Gait disturbance, Intentional dose omission, |
||||
BOSUTINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LOSARTAN POTASSIUM, LOSARTAN, PIOGLITAZONE, RANOLAZINE, |
||||
| 229 | 26912470 |
70 | 2 | |
Pyrexia, Dyspnoea, Gait disturbance, Rash, Petechiae, White blood cell count increased, |
||||
LECANEMAB, DONEPEZIL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, IRON, ERGOCALCIFEROL, LITHIUM, LITHIUM BROMATUM, PRASTERONE, |
||||
| 230 | 26912634 |
2 | ||
Pneumonia, Gait disturbance, |
||||
POMALIDOMIDE, |
||||
| 231 | 26903748 |
US |
2 | |
Deafness, Musculoskeletal stiffness, Musculoskeletal pain, Presyncope, Hypotension, Muscle spasms, Rhinorrhoea, Injection site pain, Injection site pruritus, Injection site mass, Breast pain, Nausea, Overweight, Swelling, Limb discomfort, Oxygen saturation decreased, Gait disturbance, Injection site erythema, |
||||
EVOLOCUMAB, |
||||
| 232 | 26904247 |
US |
56 | 2 |
Gait disturbance, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 233 | 26904400 |
EU |
80 | 2 |
Joint dislocation, Speech disorder, Musculoskeletal stiffness, Device issue, Device leakage, Gait disturbance, Pain in extremity, Fall, Asthenia, Foot deformity, |
||||
| 234 | 26904409 |
US |
64 | 1 |
Injection site erythema, Injection site pain, Gait disturbance, Injection site induration, Diarrhoea, |
||||
ETANERCEPT, TIRZEPATIDE, |
||||
| 235 | 26908760 |
76 | 2 | |
Fatigue, Muscular weakness, Anxiety, Irritability, Muscle spasms, Insomnia, Gait disturbance, |
||||
TERIPARATIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, PHYTONADIONE, |
||||
| 236 | 26918180 |
61 | ||
Hypersensitivity, Febrile neutropenia, Vasculitis, Vascular stenosis, Hypertransaminasaemia, Gait disturbance, Loss of consciousness, Hepatic enzyme increased, Insomnia, Mood swings, Feeling abnormal, Hypothyroidism, Vitreous floaters, Visual impairment, Circulatory collapse, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PREDNISONE, |
||||
| 237 | 26902917 |
US |
70 | 2 |
Gait disturbance, |
||||
INSULIN GLARGINE, |
||||
| 238 | 26902964 |
US |
1 | |
Gait disturbance, Injection site pain, |
||||
DUPILUMAB, |
||||
| 239 | 26903512 |
TR |
24 | 2 |
Neuromuscular toxicity, Gait disturbance, |
||||
BOTULINUM TOXIN TYPE A, ONABOTULINUMTOXINA, |
||||
| 240 | 26903596 |
GB |
62 | 1 |
Myalgia, Asthenia, Incontinence, Dizziness, Feeling abnormal, Headache, Nausea, Palpitations, Loss of personal independence in daily activities, Arrhythmia, Gait disturbance, |
||||
SPARSENTAN, |
||||
| 241 | 26897702 |
EU |
78 | 2 |
Blindness, Musculoskeletal stiffness, Glaucoma, Gait disturbance, Anal incontinence, Movement disorder, On and off phenomenon, Loss of personal independence in daily activities, Dyskinesia, Therapeutic product effect incomplete, Emotional disorder, Speech disorder, General physical health deterioration, Hallucination, visual, Stoma site erythema, Device issue, |
||||
| 242 | 26897732 |
US |
51 | 2 |
Pain, Gait disturbance, |
||||
SARILUMAB, |
||||
| 243 | 26898075 |
US |
87 | 1 |
Speech disorder, Hypophagia, Somnolence, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 244 | 26898322 |
CA |
69 | 2 |
Gait disturbance, Musculoskeletal pain, Back pain, Pain in extremity, Incorrect dose administered, Alopecia, Dysstasia, Pain, Insomnia, Drug ineffective, Vitamin C increased, Madarosis, Nail discolouration, Nail disorder, Onychomadesis, Pollakiuria, Urine analysis abnormal, Rash macular, Micturition urgency, Influenza, Pneumonia, |
||||
MIRTAZAPINE, MIRTAZAPINE, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 245 | 26898408 |
76 | 2 | |
Hip fracture, Gait disturbance, Fall, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 246 | 26898650 |
US |
75 | 2 |
Hip fracture, Peripheral swelling, Pruritus, Fall, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, |
||||
| 247 | 26898705 |
CA |
43 | |
Abdominal discomfort, Abdominal pain, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Condition aggravated, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Ear pain, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Intentional product use issue, Joint range of motion decreased, Live birth, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Wound infection, Suspected off label use, Suspected off label use, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, TOPIRAMATE, TOPIRAMATE, |
||||
| 248 | 26899059 |
US |
78 | 2 |
Intentional product misuse, Arthralgia, Product use complaint, Gait disturbance, Posture abnormal, |
||||
PANCRELIPASE, |
||||
| 249 | 26899078 |
US |
2 | |
Headache, Asthenia, Gait disturbance, Nausea, |
||||
ROZANOLIXIZUMAB, EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 250 | 26899255 |
CA |
45 | 2 |
Hyponatraemia, Vomiting, Discoloured vomit, Hallucination, Delirium, Pneumonia, Gait disturbance, Asthenia, Pyrexia, Diarrhoea, Abdominal distension, Musculoskeletal chest pain, Dysuria, Pruritus genital, Nausea, Lethargy, Confusional state, Dehydration, Electrolyte depletion, Urinary tract infection, Electrolyte imbalance, |
||||
PREDNISONE, |
||||
| 251 | 26899363 |
EU |
66 | 1 |
Muscular weakness, Fall, Gait disturbance, |
||||
GABAPENTIN, OLANZAPINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, LORAZEPAM, |
||||
| 252 | 26899401 |
AU |
53 | 1 |
Fatigue, Pruritus, Muscular weakness, Muscle spasticity, Asthenia, Off label use, Burning sensation, Abdominal distension, Fall, Gait disturbance, Dizziness, |
||||
OCRELIZUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 253 | 26899882 |
CA |
43 | 2 |
Epilepsy, Hypoaesthesia, Gait disturbance, Dry mouth, Gastrooesophageal reflux disease, Fatigue, Headache, Hypercholesterolaemia, Folliculitis, Drug hypersensitivity, Grip strength decreased, Facet joint syndrome, Hypertension, Hypersensitivity, Hepatic enzyme increased, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ALENDRONATE SODIUM, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 254 | 26900005 |
CA |
80 | 1 |
Anxiety, Arterial occlusive disease, Balance disorder, Blood test abnormal, Body temperature decreased, Breath sounds abnormal, Chronic obstructive pulmonary disease, Contusion, Dizziness postural, Dyspnoea exertional, Gait disturbance, Hyperhidrosis, Insomnia, Lacrimal disorder, Limb discomfort, Lung neoplasm malignant, Musculoskeletal discomfort, Night sweats, Rales, Road traffic accident, Stress, Wheezing, Blood pressure systolic increased, Blood pressure increased, Pain, Discomfort, Hernia, Hernia pain, Hypersomnia, Lower respiratory tract infection, Weight decreased, Dizziness, Asthenia, Injection site swelling, Injection site pain, Injection site mass, Respiratory rate increased, Arthralgia, Cough, Depression, Malaise, Pneumonia, Fatigue, Dyspnoea, Diarrhoea, Abdominal pain, Product storage error, Needle issue, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, AMLODIPINE BESYLATE, OCTREOTIDE ACETATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, |
||||
| 255 | 26900603 |
CA |
43 | 2 |
Fibromyalgia, Folliculitis, Gait disturbance, Incorrect route of product administration, Product use issue, Fatigue, Arthropathy, Autoimmune disorder, Breast cancer stage II, Abdominal discomfort, Hypocholesterolaemia, Retinitis, Visual impairment, Medication error, Off label use, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CELECOXIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OXYCODONE, OXYCODONE, OXYCODONE, |
||||
| 256 | 26900984 |
EU |
81 | 1 |
Depressed level of consciousness, Femoral neck fracture, Freezing phenomenon, Fall, Gait disturbance, Hip fracture, Faeces hard, Bowel movement irregularity, Nocturia, Muscle spasms, Hallucination, Dyskinesia, Tremor, Paraesthesia, Dementia, On and off phenomenon, Weight increased, Abnormal dreams, Stoma site discharge, Stress, Tension, |
||||
ENTACAPONE, |
||||
| 257 | 26901019 |
EU |
||
Lymphoma, Disease progression, Gait disturbance, Dysstasia, |
||||
VUTRISIRAN, |
||||
| 258 | 26901064 |
CN |
88 | 1 |
Gait disturbance, Chromaturia, Dyspnoea, |
||||
EZETIMIBE, |
||||
| 259 | 26901287 |
EU |
2 | |
Peripheral motor neuropathy, Exposure during pregnancy, Gait disturbance, |
||||
RAVULIZUMAB, |
||||
| 260 | 26901565 |
US |
||
Meniscus injury, Osteoarthritis, Back pain, Gait disturbance, |
||||
RUXOLITINIB, |
||||
| 261 | 26901719 |
DZ |
0 | 2 |
Hypoglycaemia, Gait disturbance, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 262 | 26901733 |
US |
11 | 2 |
Off label use, Inappropriate schedule of product administration, Gait disturbance, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, LEVETIRACETAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PHENOBARBITAL, CLONAZEPAM, |
||||
| 263 | 26901963 |
EG |
67 | 1 |
Nosocomial infection, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Blood pressure increased, Epistaxis, Gait disturbance, |
||||
PEMBROLIZUMAB, |
||||
| 264 | 26902014 |
US |
53 | 2 |
Joint dislocation, Joint surgery, Fall, Pain, Illness, Renal disorder, Oesophageal disorder, Condition aggravated, Rash, Gait disturbance, Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 265 | 26902566 |
US |
57 | 2 |
Musculoskeletal stiffness, Vision blurred, Injection site pain, Adrenal disorder, Hypothalamo-pituitary disorder, Product quality issue, Fall, Avulsion fracture, Secondary adrenocortical insufficiency, Malaise, Spinal pain, Back pain, Neck pain, Asthenia, Gastrointestinal sounds abnormal, Sensory loss, Musculoskeletal discomfort, Asthenia, Musculoskeletal discomfort, Laryngeal disorder, Hypoaesthesia, Oedema peripheral, Malaise, Brachial plexopathy, Ill-defined disorder, Chest pain, Muscular weakness, Ill-defined disorder, Nerve compression, Gait disturbance, Hypotension, Sinus bradycardia, Weight increased, Eyelid ptosis, Dizziness, Muscular weakness, Gait disturbance, Headache, Haematuria, |
||||
METHYLPREDNISOLONE, BACLOFEN, LEVOTHYROXINE SODIUM, METHYLPREDNISOLONE, LIOTHYRONINE SODIUM, ERGOCALCIFEROL, ESTRADIOL, |
||||
| 266 | 26902605 |
EU |
65 | 1 |
Abdominal hernia, Fatigue, Catheter site erythema, Freezing phenomenon, Dyskinesia, Catheter site paraesthesia, Catheter site induration, Diarrhoea, On and off phenomenon, Headache, Catheter site pain, Catheter site warmth, Catheter site discomfort, Bradykinesia, Catheter site induration, Gait disturbance, Catheter site swelling, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, LOSARTAN, AMLODIPINE BESYLATE, BUPROPION HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ALLOPURINOL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PRAMIPEXOLE, |
||||
| 267 | 26902626 |
EU |
77 | 2 |
Muscle rigidity, Therapeutic product effect incomplete, Restlessness, Hypokinesia, Parkinsonian gait, Mobility decreased, Gait disturbance, On and off phenomenon, Tremor, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SAFINAMIDE MESYLATE, ROTIGOTINE, ROTIGOTINE, |
||||
| 268 | 26907828 |
7 | 1 | |
Papilloedema, Extraocular muscle disorder, Leukaemic infiltration, Leukaemia recurrent, Gait disturbance, Diplopia, Intracranial pressure increased, Subdural haematoma, Cerebral mass effect, |
||||
CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEUCOVORIN CALCIUM, MERCAPTOPURINE, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, |
||||
| 269 | 26908290 |
68 | 1 | |
Drug intolerance, Adverse drug reaction, Gait inability, Gait disturbance, Neck pain, Headache, Arthralgia, Asthenia, Muscle atrophy, Brain fog, Chronic inflammatory demyelinating polyradiculoneuropathy, Condition aggravated, |
||||
EVOLOCUMAB, ROSUVASTATIN, INCLISIRAN, BEMPEDOIC ACID, ALIROCUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 270 | 26891970 |
CA |
43 | 2 |
Epilepsy, Hypoaesthesia, Gait disturbance, Dry mouth, Gastrooesophageal reflux disease, Fatigue, Headache, Hypercholesterolaemia, Folliculitis, Drug hypersensitivity, Grip strength decreased, Facet joint syndrome, Hypertension, Hypersensitivity, Hepatic enzyme increased, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 271 | 26891972 |
US |
77 | |
Fall, Limb injury, Sinus disorder, Fatigue, Fall, Skin laceration, Gait disturbance, Muscular weakness, Headache, Dizziness, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CARVEDILOL, ALPRAZOLAM, ACETAMINOPHEN, SILDENAFIL CITRATE, SILDENAFIL, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, TREPROSTINIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IRON, FUROSEMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOCETIRIZINE DIHYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, AMIODARONE HYDROCHLORIDE, |
||||
| 272 | 26892235 |
US |
46 | 2 |
Swollen joint count increased, Arthralgia, Discomfort, Fatigue, Gait disturbance, Joint swelling, |
||||
SARILUMAB, PREDNISONE, GOLIMUMAB, |
||||
| 273 | 26893134 |
US |
74 | 1 |
Transient ischaemic attack, Epistaxis, Cardiac ventricular thrombosis, Gastrointestinal surgery, Myocardial infarction, Hypoacusis, Localised infection, Contusion, Gait disturbance, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 274 | 26893579 |
US |
2 | |
Gait disturbance, Abdominal distension, |
||||
IMATINIB MESYLATE, |
||||
| 275 | 26893944 |
US |
73 | 1 |
Unresponsive to stimuli, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, MIRABEGRON, NITROGLYCERIN, SERTRALINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, |
||||
| 276 | 26893998 |
US |
2 | |
Seizure, Pain in extremity, Gait disturbance, |
||||
TROFINETIDE, |
||||
| 277 | 26894028 |
US |
23 | 1 |
Severe myoclonic epilepsy of infancy, Status epilepticus, Gait disturbance, Movement disorder, Seizure, Tonic convulsion, Fatigue, Rhinovirus infection, Parainfluenza virus infection, Pneumonia staphylococcal, Lung opacity, Feeding tube user, Somnolence, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, DIAZEPAM, LORAZEPAM, LORAZEPAM, CLONAZEPAM, ISOTRETINOIN, ISOTRETINOIN, LORATADINE, LORATADINE ORAL, MELATONIN, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, SACCHAROMYCES CEREVISIAE, FISH OIL, IRON, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, PYRITHIONE ZINC, PYRITHIONE ZINC, LANOLIN, LEVETIRACETAM, BRIVARACETAM, BRIVARACETAM, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, TOPIRAMATE, |
||||
| 278 | 26894353 |
US |
79 | 2 |
Meningitis bacterial, Off label use, Metabolic encephalopathy, Gait disturbance, Major depression, Muscular weakness, Gait disturbance, Vascular dementia, Anaemia, Fall, Hyperlipidaemia, Hypertensive heart disease, Myelodysplastic syndrome, Neutropenia, Pancytopenia, Sepsis, |
||||
VENETOCLAX, VENETOCLAX, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 279 | 26894525 |
EU |
70 | 1 |
Gait disturbance, Cystitis, Fatigue, Hallucination, visual, Orthostatic intolerance, Dysphagia, Choking, Asthenia, Limb discomfort, Abnormal dreams, Dementia, Cognitive disorder, Balance disorder, Salivary hypersecretion, Speech disorder, Freezing phenomenon, Bradykinesia, Therapeutic product effect incomplete, Fall, Therapeutic product effect variable, Stoma site infection, General physical health deterioration, Hypersomnia, Rapid eye movement sleep behaviour disorder, On and off phenomenon, Orthostatic hypotension, Syncope, |
||||
CLOZAPINE, RIVASTIGMINE, ENTACAPONE, |
||||
| 280 | 26894779 |
82 | 2 | |
Back pain, Gait disturbance, Arthritis, |
||||
NIFEDIPINE, CLONIDINE, |
||||
| 281 | 26895121 |
CA |
47 | 2 |
Abdominal distension, Blood iron decreased, Insomnia, Movement disorder, Pruritus, Dyspepsia, Alopecia, Skin exfoliation, Fatigue, Flatulence, Diarrhoea, Gait disturbance, Decreased appetite, Dry eye, Concomitant disease aggravated, Ageusia, Eye pruritus, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, |
||||
| 282 | 26895915 |
US |
60 | 2 |
Hypertension, Blood iron decreased, Gait disturbance, Pain, |
||||
LENVATINIB, |
||||
| 283 | 26895961 |
EU |
84 | 2 |
Drug ineffective, Gait disturbance, Peripheral swelling, Cystitis, Tinea pedis, Onychoclasis, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 284 | 26896278 |
CA |
43 | 2 |
Epilepsy, Hypoaesthesia, Gait disturbance, Dry mouth, Gastrooesophageal reflux disease, Fatigue, Headache, Hypercholesterolaemia, Folliculitis, Drug hypersensitivity, Grip strength decreased, Facet joint syndrome, Hypertension, Hypersensitivity, Hepatic enzyme increased, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 285 | 26896489 |
BR |
1 | |
Gait disturbance, Neuropathy peripheral, Back pain, Condition aggravated, Product use issue, Drug ineffective, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, QUETIAPINE, QUETIAPINE, QUETIAPINE, QUETIAPINE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, GLYBURIDE, GLYBURIDE, GLYBURIDE, GLYBURIDE, GLYBURIDE, GLYBURIDE, GLYBURIDE, GLYBURIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, |
||||
| 286 | 26896698 |
CA |
2 | |
Adverse event, Clostridium difficile infection, Diarrhoea, Syncope, Blood test abnormal, Gait disturbance, Product dose omission issue, Disease progression, Vomiting, Asthenia, Fatigue, Abdominal discomfort, Weight decreased, Nausea, Dizziness, Fall, Asthenia, |
||||
NINTEDANIB, |
||||
| 287 | 26896701 |
US |
59 | 2 |
Dyspnoea, Product physical issue, Cold sweat, Gait disturbance, Tongue disorder, Asthma, |
||||
| 288 | 26896846 |
PE |
34 | 1 |
Foot fracture, Cast removal, Gait inability, Ligament sprain, Physiotherapy, Gait disturbance, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 289 | 26896988 |
63 | 2 | |
Dizziness, Abdominal pain upper, Gait disturbance, Injection site bruising, Drug ineffective, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 290 | 26897091 |
US |
86 | 2 |
Breast cancer female, Malignant neoplasm progression, Diarrhoea, Fluid intake reduced, Decreased appetite, Gait disturbance, Hypertension, |
||||
TUCATINIB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 291 | 26897390 |
US |
2 | |
Fatigue, Gait disturbance, |
||||
NUSINERSEN, NUSINERSEN, |
||||
| 292 | 26897419 |
US |
75 | 2 |
Influenza like illness, Diarrhoea, Pancreatic failure, Abdominal distension, Gait disturbance, Ankle fracture, Abdominal pain upper, Faeces discoloured, |
||||
PANCRELIPASE, |
||||
| 293 | 26897530 |
US |
8 | 1 |
Gait disturbance, Arthralgia, Off label use, |
||||
PEGVALIASE-PQPZ, |
||||
| 294 | 26886705 |
EU |
60 | 2 |
Chronic inflammatory demyelinating polyradiculoneuropathy, Osteoporotic fracture, Leukopenia, Therapy partial responder, Emotional disorder, Quadriparesis, Skin infection, Bedridden, Product availability issue, Gait disturbance, Hypotonia, Hyporeflexia, Muscle atrophy, |
||||
HUMAN IMMUNOGLOBULIN G, RITUXIMAB, PREDNISONE, METHYLPREDNISOLONE, AZATHIOPRINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 295 | 26887031 |
US |
60 | 1 |
Colonoscopy, Gait disturbance, Spinal operation, Eczema, Intentional product misuse, Musculoskeletal disorder, Therapy interrupted, Eczema eyelids, Sensitivity to weather change, Psoriasis, |
||||
APREMILAST, APREMILAST, APREMILAST, |
||||
| 296 | 26887611 |
US |
2 | |
Gait disturbance, |
||||
TIRZEPATIDE, |
||||
| 297 | 26887623 |
56 | ||
Suicidal ideation, Condition aggravated, Depression, Dizziness, Dissociation, Arthralgia, Visual impairment, Gait disturbance, Food intolerance, Heart rate irregular, Muscular weakness, Anxiety, Off label use, |
||||
| 298 | 26887795 |
JP |
82 | 2 |
Pemphigoid, Muscular weakness, Gait disturbance, Urinary tract infection, |
||||
LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 299 | 26887821 |
US |
75 | 1 |
Gait disturbance, Peripheral swelling, Asthenia, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 300 | 26887968 |
US |
2 | |
Gait disturbance, Constipation, |
||||
TROFINETIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30